Skip to main content
Caplight Logo









Impiricus

Impiricus

Private
Atlanta, GeorgiaHealthcare & Life Scienceshttps://impiricus.com/

Last Round

Seed

Apr 26, 2022

Est. Valuation

$5.5M

Total Funding Raised

$3.49M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Impiricus is a healthcare technology company that provides an AI-powered engagement platform to ethically connect physicians with pharmaceutical company resources.

Sector

Healthcare & Life Sciences

Verticals

NLP & Conversational AI, Enterprise Communication, Patient Engagement

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

HCP engagementhealthcare professional engagementpharma marketingAI engagement enginelife sciences softwareenterprise SaaSpharma techconversational AIdata as a serviceDaaShealthcare data analyticsAI agentic platformpharma sales enablementhealthcare communication platformmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Impiricus Comparables

Compare Impiricus with similar companies based on industry and business-model similarity.

Impiricus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ODAIA
79%
PharmaForceIQ
76%
Doceree
70%

Impiricus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 26, 2022
Pre SeedApr 2, 2021

Key People

Founding team and executive leadership

Sandy Donaldson

Co-Founder, President Chief Strategy Officer

Founding Team

Or Maoz

Chief Technology Officer

Executive Team

Steve Miller

Chief Financial Officer

Executive Team

Shuo Jiang

Chief Operating Officer

Executive Team

Impiricus Investors

Notable investors and investment history

Impiricus investors
InvestorRounds
Atlanta Tech VillagePre Seed
Surface VenturesSeed
FCA Venture PartnersSeed
Johnson Venture PartnersPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 16, 2026

    Grew 21% QoQ, adding 34 employees.

  • Dec 27, 2025

    Added GlaxoSmithKline as a customer in the pharmaceutical industry.

Impiricus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Impiricus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Impiricus's valuation, stock price, and market status.

Firmographic Details

HeadquartersAtlanta, Georgia
Employee Range194
Year Founded2020
Last FundingApr 26, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?